Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
To access this article, please choose from the options below
PII: S0021-9150(09)00915-0
doi:10.1016/j.atherosclerosis.2009.10.041
© 2009 Elsevier Ireland Ltd. All rights reserved.
